70NANB24H071
Cooperative Agreement
Overview
Grant Description
Purpose: There currently exists a need in the biopharmaceutical industry for a sensor to accurately detect cell and metabolite properties in real time. Researchers in this phase I propose to develop an artificial intelligence (AI) deep learning system that seeks to fill this need.
Activities to be performed: Activities to be performed will include conducting experiments, calibrations, measurements, and tests to prove the feasibility of the research.
Expected outcomes: This research will advance the safe and efficient adoption of contactless (AI) deep learning sensing systems for control of a variety of bioreactor environments.
Intended beneficiaries: This research will benefit the biopharmaceutical industry and the near infrared (NIR) and Raman spectroscopy market.
Subrecipient activities: The recipient plans to subaward funds for development of algorithms, data analysis and related experiments.
Activities to be performed: Activities to be performed will include conducting experiments, calibrations, measurements, and tests to prove the feasibility of the research.
Expected outcomes: This research will advance the safe and efficient adoption of contactless (AI) deep learning sensing systems for control of a variety of bioreactor environments.
Intended beneficiaries: This research will benefit the biopharmaceutical industry and the near infrared (NIR) and Raman spectroscopy market.
Subrecipient activities: The recipient plans to subaward funds for development of algorithms, data analysis and related experiments.
Awardee
Funding Goals
TO EXPLORE THE TECHNICAL MERIT OR FEASIBILITY OF AN INNOVATIVE IDEA OR TECHNOLOGY WITH THE AIM OF DEVELOPING A VIABLE PRODUCT OR SERVICE THAT WILL BE INTRODUCED TO THE COMMERCIAL MARKETPLACE. TO STRENGTHEN THE ROLE OF INNOVATIVE SMALL BUSINESS CONCERNS (SBCS) IN FEDERALLY-FUNDED RESEARCH OR RESEARCH AND DEVELOPMENT (R/R&D) AND TO: (1) STIMULATE TECHNOLOGICAL INNOVATION; (2) USE SMALL BUSINESS TO MEET FEDERAL R/R&D NEEDS; (3) FOSTER AND ENCOURAGE PARTICIPATION BY SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESSES AND BY WOMEN-OWNED SMALL BUSINESSES IN TECHNOLOGICAL INNOVATION; AND (4) INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL R/R&D, THEREBY INCREASING COMPETITION, PRODUCTIVITY, AND ECONOMIC GROWTH.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Quincy,
Massachusetts
02169-2441
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 11/15/24 to 02/15/25.
Applied Imaging Solutions was awarded
Cooperative Agreement 70NANB24H071
worth $99,759
from the National Institute of Standards and Technology in May 2024 with work to be completed primarily in Quincy Massachusetts United States.
The grant
has a duration of 9 months and
was awarded through assistance program 11.620 Science, Technology, Business and/or Education Outreach.
The Cooperative Agreement was awarded through grant opportunity Small Business Innovation Research (SBIR) Program Phase I.
SBIR Details
Research Type
SBIR Phase I
Title
Hyperspectral Imaging with AI/Deep Learning For Online Monitoring of NISTCHO Viability and Cell Culture Metabolltes in Real-time
Abstract
Within the biopharmaceutical sector, there exist the need for a contactless multiplex sensor, which can accurately detect cell viability and metabolite levels in real time for precise feedback control of a bioreactor environment. The use of hyperspectral imaging (HSI) allows for efficient, fully contactless collection of large spectral datasets for metabolite quantification. Here, we report the development of an interpretable AI/deep learning system a convolution metabolite regression (CMR) approach that detects cell viability, glucose, and lactate concentrations using label-free contactless HS images of media samples containing Chinese hamster ovary (NISTCHO) cell grown in an expansion bioreactor. We propose using a dataset of <500 HS images of a microfluidics chip with flowing CHOH cells and spent media online in order to predict NISTCHO cell viability, total cell count, glucose, and lactate based using the CMR model and a training set of ground truth readings of each of these material attributes and process parameters in real-time. Collectively, this work will advance the safe and efficient adoption of contactless AI/deep learning sensing systems for a fine control of a variety of bioreactor environments.
Topic Code
2
Solicitation Number
2024-NIST-SBIR-01
Status
(Complete)
Last Modified 1/7/25
Period of Performance
5/15/24
Start Date
2/15/25
End Date
Funding Split
$99.8K
Federal Obligation
$0.0
Non-Federal Obligation
$99.8K
Total Obligated
Activity Timeline
Transaction History
Modifications to 70NANB24H071
Additional Detail
Award ID FAIN
70NANB24H071
SAI Number
70NANB24H071_1
Award ID URI
EXE
Awardee Classifications
Small Business
Awarding Office
1333ND DEPT OF COMMERCE NIST
Funding Office
1333ND DEPT OF COMMERCE NIST
Awardee UEI
ESK8A5EKZYM8
Awardee CAGE
None
Performance District
MA-08
Senators
Edward Markey
Elizabeth Warren
Elizabeth Warren
Modified: 1/7/25